Target intelligence / Profile preview

RNA, U6 small nuclear 611, pseudogene (RNU6-611P)

Target
RNU6-611P
Molecular classification
Pseudogene
01

Overview

RNU6-611P encodes a non-functional RNA similar to U6 small nuclear RNA but is classified as a pseudogene, meaning it does not produce a functional product and is not directly involved in pre-mRNA splicing or other well-characterized cellular activities[4]. U6 small nuclear RNA (the parent gene) is an essential component of the spliceosome required for intron excision in pre-mRNA[3][5]. Pseudogenes like RNU6-611P typically arise by duplication, retrotransposition, or genomic rearrangement; while some pseudogenes are implicated in gene regulation or disease, there is no evidence for any such role for RNU6-611P[2][4]. This molecule is catalogued in genome databases (e.g., NCBI, Ensembl)[4] and not considered a therapeutic target, receptor, transporter, or enzyme. The name is not misspelled; it follows database conventions for pseudogene nomenclature[4]. RNU6-611P is not a receptor, enzyme, transporter, or direct drug target, and lacks structured drug/gene interaction data or disease links. Most functional and disease-related roles for U6 pseudogenes remain speculative; this specific entry has no substantiated research context for therapies or biomarker use.

Other names
RNU6-611P
02

Biological functions

No direct biological function; pseudogene
03

Disease associations

No disease association or regulatory function described for this pseudogene; generic U6 snRNA and some pseudogenes can act as ceRNAs in rare contexts[2], but no evidence for RNU6-611P

Beyond the preview

Go deeper on RNA, U6 small nuclear 611, pseudogene (RNU6-611P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 611, pseudogene (RNU6-611P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call